• Thematic Report
    June 10, 2026

    Artificial Intelligence (AI) is redefining how Banking, Financial Services, and Insurance (BFSI) enterprises make decisions, execute workflows, and create value. While adoption has accelerated, fragmented data ecosystems, legacy operating models, siloed execution, and limited accountability for…
  • Thematic Report
    Feb. 11, 2026

    Claims is no longer a back-office function in Property and Casualty (P&C) insurance; it is a customer trust, cost control, and competitive differentiation enabler. As insurers face service and repair inflation, climate-driven catastrophe volatility, social inflation…
  • Blog
    Dec. 03, 2025

    Litigation in Insurance refers to the process where disputes over claims or coverage move from negotiation or adjustment into the legal system. It typically involves attorneys, courts, and formal proceedings, marking the point where a claim stops being a file and becomes…
  • LinkedIn Live
    Nov. 19, 2025

    In an evolving landscape where analyst relations (AR) shape market perception and business success, leaders continued to look for proven tactics embraced by experienced AR professionals. Everest Group’s Katrina Menzigian, along with industry experts from other…
  • State of the Market
    Oct. 29, 2025

    The Property and Casualty (P&C) insurance industry is operationally transforming in response to rising claims costs, regulatory pressures, and the need for agility in distribution and servicing. Insurers are moving beyond cost-driven outsourcing to pursue AI-enabled,…
  • PEAK Matrix®
    Sep. 10, 2025

    The Property and Casualty (P&C) insurance industry is undergoing rapid transformation, driven by volatile market conditions, cost pressures, and increasing operational complexity. As insurers strive for profitable growth and agility, they are reconfiguring core operations and…
  • July 09, 2025

    Property and casualty (P&C) enterprises are facing mounting pressures from frequent catastrophes, supply chain disruptions, geopolitical tensions, and both economic and social inflation. These forces are driving enterprises to seek a timely, data-driven subrogation recovery as a…
  • Market Insights™
    March 12, 2024

  • Market Insights™
    March 12, 2024

  • Market Insights™
    March 12, 2024

  • Provider Compendium
    March 08, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Webinar
    March 07, 2024

    Last year, the outsourcing industry faced a noticeable slowdown in demand. Now, with nudges at a potential recovery in the latter part of 2024, enterprises in the APAC region should proactively prepare for the possibility of…
  • Thematic Report
    March 07, 2024

    Last year, the outsourcing industry faced a noticeable slowdown in demand. Now, with nudges at a potential recovery in the latter part of 2024, enterprises in the APAC region should proactively prepare for the possibility of…
  • Viewpoint
    Feb. 05, 2024

    In the rapidly evolving life sciences landscape, where the pursuit of innovative therapies and life-saving drugs never ceases, science and technology are increasingly playing a vital role. High-performance Computing (HPC) stands at the forefront of this…
  • PEAK Matrix®
    Jan. 18, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Deciding betweenServiceNow’s dedicated and shared instances can be challenging for organizations. By comparing the options against seven key parameters ranging from organizational size and business process complexity to the cost of ownership and customization options, enterprises…
  • Blog
    June 16, 2023

    Advances in Generative Artificial Intelligence (GAI) have sparked interest in its potential to drive growth and innovation in the biopharma and medical devices industries. Despite challenges and regulations, the life sciences industry is actively exploring GAI’s…
  • State of the Market
    May 31, 2023

    Amid the global COVID-19 pandemic, the Life Sciences (LS) industry faced unprecedented challenges that prompted the accelerated adoption of IT services across its value chain. To ensure business continuity, LS enterprises swiftly embraced virtual ecosystems facilitated…
  • Provider Compendium
    May 03, 2023

    Core administrative operations are a vital component of healthcare plan and payer organizations. However, with the increasing complexity of delivery and implementation options, the legacy Core Administration Processing Solution (CAPS) falls short. The key core administrative…
  • Viewpoint
    May 01, 2023

    The COVID-19 outbreak compelled the life sciences industry to innovate and transform digitally. However, the current global macroeconomic and socio-political uncertainty, coupled with increasing research and development IT expenditure, have created immense pressure on the pharmaceutical…

Items per page